Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology
Y Collins, K Holcomb, E Chapman-Davis… - Gynecologic …, 2014 - Elsevier
Objectives To review the extent of health disparities in gynecologic cancer care and
outcomes and to propose recommendations to help counteract the disparities. Methods We …
outcomes and to propose recommendations to help counteract the disparities. Methods We …
Adenosquamous histology predicts a poor outcome for patients with advanced‐stage, but not early‐stage, cervical carcinoma
JH Farley, KW Hickey, JW Carlson… - … Journal of the …, 2003 - Wiley Online Library
BACKGROUND The objective of this study was to compare survival between patients with
adenocarcinoma and patients with adenosquamous carcinoma of the cervix. METHODS …
adenocarcinoma and patients with adenosquamous carcinoma of the cervix. METHODS …
MEK1/2 inhibitors in the treatment of gynecologic malignancies
CR Miller, KE Oliver, JH Farley - Gynecologic oncology, 2014 - Elsevier
Mitogen-activated protein kinases (MAPKs) are a family of ubiquitous eukaryotic signal
transduction enzymes which link extracellular stimuli to intracellular gene expression …
transduction enzymes which link extracellular stimuli to intracellular gene expression …
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
Small cell carcinoma of the ovary of hypercalcemic type (SCCOHT) is an extremely rare,
aggressive cancer affecting children and young women. We identified germline and somatic …
aggressive cancer affecting children and young women. We identified germline and somatic …
Factors associated with survival disparities between non-Hispanic Black and White patients with uterine cancer
CW Kucera, C Tian, CM Tarney, C Presti… - JAMA network …, 2023 - jamanetwork.com
Importance Disparities in survival exist between non-Hispanic Black (hereafter, Black) and
non-Hispanic White (hereafter, White) patients with uterine cancer. Objective To investigate …
non-Hispanic White (hereafter, White) patients with uterine cancer. Objective To investigate …
[HTML][HTML] A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)
GJ Weiss, J Waypa, L Blaydorn, J Coats… - British journal of …, 2017 - nature.com
Background: Pembrolizumab (P) is an anti-PD-1 antibody that blocks the interaction
between programmed cell death protein 1 (PD-1) on T-cells and PD-L1 and PD-L2 on …
between programmed cell death protein 1 (PD-1) on T-cells and PD-L1 and PD-L2 on …
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum …
Purpose We examined disparities in prognosis between patients with ovarian clear cell
carcinoma (OCCC) and serous epithelial ovarian cancer (SOC). Methods We reviewed data …
carcinoma (OCCC) and serous epithelial ovarian cancer (SOC). Methods We reviewed data …
Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer
CA Hamilton, GL Maxwell, MR Chernofsky… - Gynecologic …, 2008 - Elsevier
BACKGROUND: Malignant ascites often has a profound impact on the quality of life of
patients with refractory ovarian cancer. Current treatments, including dietary, medical, and …
patients with refractory ovarian cancer. Current treatments, including dietary, medical, and …
Equal care ensures equal survival for African‐American women with cervical carcinoma
JH Farley, JF Hines, RR Taylor, JW Carlson… - Cancer, 2001 - Wiley Online Library
BACKGOUND. It was the purpose of this study to investigate whether race is an independent
prognostic factor in the survival of patients with cervical carcinoma in a health care system …
prognostic factor in the survival of patients with cervical carcinoma in a health care system …
Promoting health equity in the era of COVID-19
JH Farley, J Hines, NK Lee… - Gynecologic …, 2020 - gynecologiconcology-online.net
Across the United States, it is now apparent that the COVID-19 virus is exacerbating existing
societal biases and longstanding inequities in health care, resulting in an excess of …
societal biases and longstanding inequities in health care, resulting in an excess of …